• • 회사소개
  • 경영진
  • 경영성과
• • R&D Story
  • Core technology
    • What is FreSHtracer?
    • 세포 내 GSH 측정
  • 연구 분야
  • 연구 성과
• • Cell therapy
    • 세포치료제
    • 엑소좀
  • Cell quality management
    • FreSHcell Q
    • Measurement kit
    • Cell culture media
  • 파이프라인
  • GMP 센터
• • Cell quality management system
  • CDMO Service
  • 줄기세포치료제 개발
  • Open Innovation
• • IR
    • 공시 및 공고
    • IR자료실
  • PR
    • 보도자료
    • PR 자료실

• • Cell2in
  • Executives
  • Achievement
• • R&D Story
  • Core technology
    • What is FreSHtracer?
    • Intracellular GSH measurement
  • Field of R&D
  • R&D result
• • Cell therapy
    • Cell therapy drug
    • Exosome
  • Cell quality management
    • FreSHcell Q
    • Measurement kit
    • Cell culture media
  • Pipeline
  • GMP center
• • Cell quality management system
  • CDMO Service
  • New drug development
  • Open Innovation
• • IR
    • Notice
    • IR Documents
  • PR
    • Press Releases
    • PR Materials

• • Cell2in
  • 员工简介
  • 成长现状
• • 研究背景
  • 核心技术
    • 什么是 FreSHTracer
    • 测量细胞GSH含量
  • 研究领域
  • 研究成果
• • 细胞疗法
    • 细胞治疗剂
    • 外泌体
  • 细胞质量管理
    • FreSHcell Q
    • 试剂盒
    • 细胞培养液
  • Pipeline
  • GMP生产中心
• • 细胞质量管理体系
  • CDMO 服务
  • 新药研发
  • Open Innovation
• • IR
    • 公告
    • IR 文件
  • PR
    • PR
    • PR 材料

• EN
  • KO
  • CN

Press Releasescelltoin2022-06-27T15:51:11+09:00